Kevin Oh

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results”.

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Nature Medicine(2023)10.1038/s41591-023-02392-7

N/A

1.6DataRank · unranked

66 citations

Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy U. Lin, Beth Overmoyer +28 more

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

Neuro-Oncology(2023)10.1093/neuonc/noad236

N/A

0.323DataRank · unranked

6 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Advanced imaging to assess longitudinal vascular changes in brain metastases treated with immune checkpoint inhibition.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2529

N/A

0DataRank · unranked

0 citations

Ken Chang, Andrew Beers, Kyrre E. Emblem, Jayashree Kalpathy–Cramer, Eudocia Q. Lee +15 more

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554868

N/A

0DataRank · unranked

0 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more